Serabi Gold plc ("Serabi" or the "Company") Appointment of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Serabi Gold plc ("Serabi" or the "Company") Appointment of Director and Award of Share Options

LONDON, Sept. 30, 2014 (GLOBE NEWSWIRE) -- Serabi Gold plc (AIM:SRB) (TSX: SBI ), the Brazilian focused gold mining and development company, is pleased to announce the appointment of Mr. Felipe Swett as a Non-Executive Director of the Company with immediate effect.

Mr. Swett is a Partner and heads the asset management team at Asset Chile, a Chilean-based investment bank. Mr. Swett joined Asset Chile in 2003 as an Analyst and as part of the corporate finance team and has led the Asset Management division since 2010. Mr Swett holds a degree in Civil Engineering with a Diploma in Environmental Engineering from the Pontificia Universidad Católica de Chile and an MBA from the Kellogg School of Management, Northwestern University.

Mr. Felipe Swett Lira, aged 35, has held the following directorships and /or partnerships in the last 5 years:

Current Past                                                                                            
Hinman Ltda None
Asset Chile S.A.  
Asset Administradora General de Fondos S.A.  
Asset S.A.  
Foresta Administradora de Fondos de Inversion S.A.  
Sociedad Forestal S.A.  
Las Petacas Spa.  
Domeyko Spa.  
Inmobiliaria Santa Fe Ltda.  

Mr. Swett currently holds no ordinary shares in Serabi.

There is no further information on Mr. Swett required to be disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies.

The Company also announces that the board of directors of Serabi (the "Board") has agreed to award in aggregate 3,200,000 new options over ordinary shares to certain of its non-executive Directors (representing 0.34% of the current issued share capital of 656,389,204 ordinary shares). The options are exercisable at 5.50 pence which compares to the closing mid-market share price in London of 5.50 pence per ordinary share on 29 September 2014. The option awards are as follows:

Director                                                                                                        Number of new options over Ordinary Shares
Nicolas Banados 1,200,000
Hector Aquiles 1,000,000
Felipe Swett 1,000,000
  3,200,000

None of these Directors currently hold any share options in the Company and this award is in-line with previous awards made to other non-executive Directors.

The options have been granted under the Serabi Mining 2011 Share Option Plan (the "2011 Plan") which the Company adopted on 28 January 2011. On 24 June 2014 shareholders approved the continuing grant of options under the 2011 Plan until 23 June 2017. The options granted will vest in three equal tranches, with one-third vesting and being exercisable immediately on award, one-third vesting on the first anniversary of the award and the remainder vesting on the second anniversary of the award and the options will lapse three years after the date of the award.

Enquiries:  
   
Serabi Gold plc  
Michael Hodgson Tel: +44 (0)20 7246 6830
Chief Executive Mobile: +44 (0)7799 473621
   
Clive Line Tel: +44 (0)20 7246 6830
Finance Director Mobile: +44 (0)7710 151692 
   
Email: contact@serabigold.com  
Website:  www.serabigold.com  
   
Beaumont Cornish Limited  
Nominated Adviser   
Roland Cornish Tel: +44 (0)20 7628 3396
Michael Cornish Tel: +44 (0)20 7628 3396
   
Peel Hunt LLP  
UK Broker  
Matthew Armitt Tel: +44 (0)20 7418 9000
Ross Allister Tel: +44 (0)20 7418 9000
   
Blytheweigh   
Financial PR  
Tim Blythe Tel: +44 (0)20 7138 3204
  Mobile: +44 7816 924626
Halimah Hussain Tel: +44 (0)20 7138 3204
  Mobile: +44 7725 978141

Copies of this release are available from the Company's website at www.serabigold.com .

Neither the Toronto Stock Exchange, nor any other securities regulatory authority, has approved or disapproved of the contents of this news release.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Discovering Innovation: Smitty's Car Wash on Public Television

Updated Category News Views 332

Innovation at Smitty's Car Wash Viewers are in for an enlightening experience as the show "Empowered with Meg Ryan" spotlights Smitty's Car Wash, a pioneer in the express tunnel car wash industry. This segment promises to challenge traditional notions of car washing, showcasing how modern methods and technology integrate to create not just services, but transformative...

Continue Reading
ASPCA® Expands Veterinary Services with New Clinic Opening

Updated Category News Views 144

ASPCA® Opens New Community Veterinary Clinic in New York The ASPCA Community Veterinary Clinic, supported by The Rachael Ray Foundation, is set to meet the needs of many pets in the local area. This opening in New York City is a crucial advancement in providing vital veterinary care to communities in need. Veterinary Services That Are Within Reach Thousands of pets in...

Continue Reading
Big Boost for European Innovation with Novo Nordisk Foundation's Grant

Updated Category News Views 91

Novo Nordisk Foundation Boosts Innovation Funding In a groundbreaking move to enhance innovation in Europe, the Novo Nordisk Foundation is investing up to DKK 5.5 billion (approximately EUR 736 million) into the BioInnovation Institute (BII). This funding is set to play a transformative role in supporting entrepreneurs and startups within the life sciences sector....

Continue Reading
Legal Challenges for 3D Systems: Investor Action Recommended

Updated Category News Views 165

Overview of the Legal Situation Recent events surrounding 3D Systems Corporation have raised significant concerns among investors. The company is currently facing a class action lawsuit that alleges violations of securities laws. Investors in 3D Systems are encouraged to stay informed about the progress of this legal challenge and consider their options moving forward....

Continue Reading
Inhibikase Therapeutics Updates: Q2 2025 Financial Overview

Updated Category News Views 135

Inhibikase Therapeutics Q2 2025 Financial Update Inhibikase Therapeutics, Inc. (NASDAQ: IKT) is making notable strides as a clinical-stage pharmaceutical company dedicated to developing innovative therapeutics aimed at addressing cardiopulmonary diseases, particularly Pulmonary Arterial Hypertension (PAH). Recently, they announced their financial results for the second...

Continue Reading